The choice of treatment and the motivations behind it impact clinical outcomes among patients with adequate control of their rheumatic disease: A real-life study
Patients with AC of their underlying RMD, whose rheumatologists prescribed their FCHO, had better outcomes than those who were prescribed SCHO. Evidence-based motivations, rheumatologists´ concern of medication shortage, and patient-related motivations were associated with FCHO.
Authors
- Guillermo Arturo Guaracha-Basáñez (ORCID: https://orcid.org/0000-0001-8060-7301)
- Diana Padilla-Ortíz
- Virginia Pascual‐Ramos (ORCID: https://orcid.org/0000-0002-7368-498X)
- Irazú Contreras-Yáñez (ORCID: https://orcid.org/0000-0001-6711-2275)
- Laura Viviana Vargas-Sánchez
- Laura L. Franco-Mejía
- Julia G. Jiménez-Decle
Institutions
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1371/journal.pone.0315478
- Citations
- 1
- Primary Topic
- Patient-Provider Communication in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.85